Matches in Wikidata for { <http://www.wikidata.org/entity/Q92505307> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q92505307 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92505307 description "scientific article published on 20 December 2019" @default.
- Q92505307 description "wetenschappelijk artikel" @default.
- Q92505307 description "наукова стаття, опублікована 20 грудня 2019" @default.
- Q92505307 description "գիտական հոդված հրատարակված 2019 թվականի դեկտեմբերի 20-ին" @default.
- Q92505307 name "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 name "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 type Item @default.
- Q92505307 label "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 label "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 prefLabel "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 prefLabel "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 P1433 Q92505307-76F61905-BF3A-46CA-8C4A-B5C715E58DE2 @default.
- Q92505307 P1476 Q92505307-62075C7F-2A99-492D-8E2B-57830B2270BB @default.
- Q92505307 P2093 Q92505307-6D88C859-05D4-44A7-AA39-844F1AC272DB @default.
- Q92505307 P2093 Q92505307-7249DC6C-D34A-422C-97B2-FABE30C29A33 @default.
- Q92505307 P2093 Q92505307-9042B78D-BC3E-4024-AA48-7564D0EF4D08 @default.
- Q92505307 P2093 Q92505307-B32A0E53-B3FC-45F3-AE6F-8A9F432493C1 @default.
- Q92505307 P2093 Q92505307-DA9927AB-4D43-4086-BDB1-3901ABA6B89E @default.
- Q92505307 P2093 Q92505307-E4C15600-F254-4A57-B7C0-7673B1A78314 @default.
- Q92505307 P275 Q92505307-674b241d-827e-4a01-93be-fdf48559f0ab @default.
- Q92505307 P2860 Q92505307-07066AA1-4E9B-42D3-9599-3E847108012F @default.
- Q92505307 P2860 Q92505307-17C6D83C-907D-41E3-BDB8-1DA741C14110 @default.
- Q92505307 P2860 Q92505307-41E158E8-0929-4DC1-A1A6-A2944AEAF231 @default.
- Q92505307 P2860 Q92505307-48E0B0C1-5BA1-490D-9FAF-22DDF1F9BEFC @default.
- Q92505307 P2860 Q92505307-5AAC157F-3B0B-4A8A-964F-ADB9A8F08C39 @default.
- Q92505307 P2860 Q92505307-604B2F41-179D-49C6-8162-3CE18058E84D @default.
- Q92505307 P2860 Q92505307-695390C6-6916-437A-A431-C3A499FAE27A @default.
- Q92505307 P2860 Q92505307-91458193-D44D-4363-872D-79D459258711 @default.
- Q92505307 P304 Q92505307-75C69AAB-350A-420B-A76C-67E3D035F179 @default.
- Q92505307 P31 Q92505307-8139F07B-CBB1-444C-8491-BC78D3313888 @default.
- Q92505307 P356 Q92505307-10E15A7F-EA4E-48C9-97B6-4CCCFA8B743B @default.
- Q92505307 P433 Q92505307-39F7ECCF-EC03-4CEB-837F-42F31173F099 @default.
- Q92505307 P478 Q92505307-752B9874-A670-4244-8D5D-92FAE5190B49 @default.
- Q92505307 P577 Q92505307-67CA4FAC-B1C2-42A6-B1EA-B3A34BF30293 @default.
- Q92505307 P6216 Q92505307-b6a58793-df72-480f-8ca8-fd997808e4b9 @default.
- Q92505307 P698 Q92505307-3C3F2C16-8AE1-4EB2-BD39-A156B3AE0E1C @default.
- Q92505307 P921 Q92505307-0181B4A6-E623-46D0-8358-B0587F59A0D4 @default.
- Q92505307 P921 Q92505307-4553F3C3-2E4A-4F2F-A1EA-41830C28888B @default.
- Q92505307 P921 Q92505307-65F29FB5-8645-43D5-AD6F-FB6819FEF176 @default.
- Q92505307 P921 Q92505307-6BCDA110-8174-4B59-957D-E0F0E9C4EBF0 @default.
- Q92505307 P932 Q92505307-050880D4-6CDC-493A-B88F-D11506DBD575 @default.
- Q92505307 P356 BR.2019.54.4.290 @default.
- Q92505307 P698 31915659 @default.
- Q92505307 P1433 Q26842305 @default.
- Q92505307 P1476 "Differential impact of anti-thymocyte globulin dosing by disease risk index in alternative donor peripheral blood stem cell transplantation in patients with acute leukemia or myelodysplastic syndrome after reduced intensity conditioning" @default.
- Q92505307 P2093 "Dong-Yeop Shin" @default.
- Q92505307 P2093 "Inho Kim" @default.
- Q92505307 P2093 "Ji Yun Lee" @default.
- Q92505307 P2093 "Mihong Choi" @default.
- Q92505307 P2093 "Soo-Mee Bang" @default.
- Q92505307 P2093 "Sung-Soo Yoon" @default.
- Q92505307 P275 Q34179348 @default.
- Q92505307 P2860 Q35078368 @default.
- Q92505307 P2860 Q37618811 @default.
- Q92505307 P2860 Q40291317 @default.
- Q92505307 P2860 Q46845322 @default.
- Q92505307 P2860 Q50967594 @default.
- Q92505307 P2860 Q58814237 @default.
- Q92505307 P2860 Q59391737 @default.
- Q92505307 P2860 Q90924993 @default.
- Q92505307 P304 "290-295" @default.
- Q92505307 P31 Q13442814 @default.
- Q92505307 P356 "10.5045/BR.2019.54.4.290" @default.
- Q92505307 P433 "4" @default.
- Q92505307 P478 "54" @default.
- Q92505307 P577 "2019-12-20T00:00:00Z" @default.
- Q92505307 P6216 Q50423863 @default.
- Q92505307 P698 "31915659" @default.
- Q92505307 P921 Q65592366 @default.
- Q92505307 P921 Q7799635 @default.
- Q92505307 P921 Q954625 @default.
- Q92505307 P921 Q976388 @default.
- Q92505307 P932 "6942147" @default.